Combination of officinal plants and their use in the treatment and/or prevention of sleep disorders
TW201902476A
New selective hdac6 inhibitors
JP2017171690A
Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for treating muscular dystrophy
EP3293293A1
Hc-cdr3-only libraries with reduced combinatorial redundancy and optimized loop length distribution
IT201600074606A1
New benzo-N-hydroxy amide compounds having antitumor activity
JP2016128504A
Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for treating muscular dystrophy
ITUB20155193A1
Physically and chemically stable oral Givinostat suspensions
EP3010496A1
Arginine for use in the treatment and/or prevention of osteoarthritis
MX370451B
Diethyl- [6- (4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl) - naphthalen-2-yl-methyl] -ammonium chloride for use in the treatment of muscular dystrophy.
EP2490682A1
Derivatives of n-hydroxybenzamide for treating hiv infections
WO2012001712A1
Iron (iii) caseinsuccinylate and method for the preparation thereof
KR20170124640A
Use of histone deacetylase inhibitors for the care of philadelphia-negative myeloproliferative syndromes
EP2228055A1
Riluzole liquid emulsions
EP2228054A1
Riluzole aqueous suspensions
WO2009071460A2
New non-selective somatostatin analogues
EP2067786A1
Novel non selective analogs of somatostatin
US2008076807A1
Alpha-amino acid derivatives with antiinflammatory activity
CN1867565A
Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes
WO2004065355A1
Monohydrate hydrochloride of the 4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylaminomethyl-naphtalen-2-yl) ester
EP1581484A1
Hydroxamic acid derivatives having anti-inflammatory action
